Vericel Corporation (VCEL) PT Raised to $72 at TD Cowen; 'The Launch of MACI Arthro Is a Key Lever to Long-Term Growth'
Tweet Send to a Friend
TD Cowen analyst Joshua Jennings raised the price target on Vericel Corporation (NASDAQ: VCEL) to $72.00 (from $60.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
